Results 171 to 180 of about 181,938 (338)

Quantitative Real‐Time MRI for the Assessment of Gastric Motility

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Current reference standards for measuring gastric emptying and motility are not considered optimal due to the time required, ionizing radiation, invasiveness, and spatial resolution. Purpose To assess gastric motility using novel real‐time dynamic magnetic resonance imaging in combination with static measurements for gastric ...
Lydia Neubauer   +14 more
wiley   +1 more source

Azathioprine-Induced Peripheral T Cell Apoptosis And Drug Response In Patients With Crohn’s Disease [PDF]

open access: yes, 2011
Background and Aim: the long time interval for a trial of thioupurine therapy and the potential side effects in spite of the proven efficacy, do not encourage their use as early therapeutic option in Crohn’s Disease (CD).
Cossu, Andrea
core  

P102 Subclinical atherosclerosis assessed by coronary artery calcium score in patients with Crohn’s disease [PDF]

open access: bronze, 2019
Beatriz Rocha   +9 more
openalex   +1 more source

Additional file 2: Table S2. of Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohnâ s disease patients in a mouse model of colitis

open access: yes, 2015
Presenting DAI score criteria. Summary of the criteria used to assign the scores added to determine the DAI in mice daily. (DOCX 13 kb)
Forte, Dorian   +14 more
openaire   +1 more source

Oral rehydration solution for the management of fluid and electrolyte disturbances in patients with an ileostomy: A scoping review

open access: yesJournal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Ileostomy creation is common among patients with colorectal cancer, diverticulitis, and inflammatory bowel disease. Surgical removal or diversion of the colon can result in nutrition complications, most notably dehydration—a leading cause of hospital readmission—and increased risk of kidney injury.
Austin J. Hoeg   +9 more
wiley   +1 more source

Effect of smoking over one pack daily on implant healing and health: A cohort study

open access: yesJournal of Periodontology, EarlyView.
Abstract Background This prospective cohort trial examines the effects of heavy smoking on peri‐implant marginal bone loss (MBL) and implant survival rates over 15 months. Methods Thirty subjects, categorized as either smokers (more than 20 cigarettes daily for over 5 years) or non‐smokers, were initially recruited with pocket depths ≤ 5 mm and at ...
Yaniv Mayer   +9 more
wiley   +1 more source

Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Children with inflammatory bowel diseases (IBD) have limited access to the available advanced therapies, given the lengthy gap between adult and pediatric approval. We aimed to review key hurdles for pediatric trials and recommend practical solutions.
Dan Turner   +21 more
wiley   +1 more source

A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn’s Disease [PDF]

open access: bronze, 2023
Matthieu Allez   +14 more
openalex   +1 more source

Therapy de‐escalation in pediatric patients with inflammatory bowel disease in remission: Data analysis from the CEDATA registry

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives There are no standardized criteria about stepping down from combination therapy (immunomodulator and tumor necrosis factor (TNF)‐alpha‐inhibitors) in children with inflammatory bowel disease (IBD) to reduce risk for side effects. Our aim was to describe how de‐escalation has been performed in a large pediatric cohort and to find ...
Sila Cekin   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy